Replies to post #178022 on Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

I don't expect them to partner off Brilacidin for a single indication. They are exploring multiple uses for Brilacidin which increases the value of the platform as positive results come in.

Others seem to think it will be partnered/sold off by indication. I don't. Time will tell the actual direction taken.





In Reply to 'baytdr'
the question that's been nagging me is why no partner for ABSSSI?

[Waverunner1]

because they want to package Brilacidin as a platform that also includes anti-inflammatory indications as that will produce the highest valuation. So they will wait for UP/OM full results.

the question that's been nagging me is why no partner for ABSSSI?